Abstract
Purified K1 polysaccharide enhanced the virulence of non-K1Escherichia coli species when given by orogastric feeding to neonatal rats. Neonatal rats developedE. coli bacteremia when K1 polysaccharide was given concomitantly with non-K1E. coli, whereasE. coli bacteremia did not develop when non-K1E. coli was given alone.E. coli K1 species did cause bacteremia and meningitis when fed to neonatal rats. The mechanism by which k1 polysaccharide enhances virulence can be studied with this model of bacteremia development in neonatal rats.
Similar content being viewed by others
Literature Cited
Davis, C. P., Avots-Avotins, A. E., Fader, R. C. 1981. Evidia coli and the effect of neuraminic acid and colominic acid on adherence. Infection and Immunity34:944–948.
Glode, M. P., Sutton, R., Moxon, E. R., Robbins, J. B. 1977. Pathogenesis of neonatal Escherichia coli meningitis: induction of bacteremia and meningitis in infant rats fed E. coli K1. Infection and Immunity16:75–80.
Gotschlich, E. C., Liu, T. H., Artenstein, M. S. 1969. Human immunity to the Meningococcus. Preparation and immunochemical properties of group A, group B, and group C meningococcal polysaccharides. Journal of Experimental Medicine129:1349–1365.
Horwitz, M. A., Silberstein, S. C. 1980. Influence of Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes. Journal of Clinical Investigations65:82–94.
Howard, C. J., Glynn, A. A. 1971. The virulence for mice of strains of Escherichia coli related to the effects of K antigen on their resistance to phagocytosis and killing by complement. Immunology20:767–777.
Kaijser, B. 1973. Immunology of Escherichia coli K antigen and its relation to urinary-tract infection. Journal of Infectious Disease127:670–677.
Moxon, E. R., Ostrow, P. T. 1977. Haemophilus influenzae meningitis in infant rats: role of bacteremia in pathogenesis of age dependent inflammatory responses in cerebrospinal fluid. Journal of Infectious Disease135:303–307.
Robbins, J. B., McCracken, G. H., Gotschlich, E. C., Orskov, I., Hanson, L. A. 1974. Escherichia coli K1 capsular polysaccharide associated with neonatal meningitis. New England Journal of Medicine290:1216–1220.
Sarff, L. D., McCracken, G. H., Schiffer, M. S., Glode, M. P., Robbins, J. B., Orskov, I., Orskov, F. 1975. Epidemiology of Escherichia coli K1 in healthy and diseased newborns. The Lanceti:1099–1104.
Stevens, P., Huang, S. N., Welch, W. D., Young, L. S. 1978. Restricted complement activation by Escherichia coli with the K1 capsular serotype: A possible role in pathogenicity. Journal of Immunology121:2174–2180.
Van Dijk, W. C., Verburgh, H. A., Peters, R., Van DerTol, M. E., Peterson, P. K., Verhoef, J. 1979. Escherichia coli K antigen in relation to serum induced lysis and phagocytosis. Journal of Medical Microbiology12:123–130.
Van Dijk, W. C., Verbrugh, H. A., Van DerTol, M. E., Peters, R., Verhoef, J. 1979. Role of Escherichia coli K capsular antigens during complement activation, C3 fixation and opsonization. Infection and Immunity25:603–609.
Wolberg, G., Dewitt, C. W. 1969. Mouse virulence of K(L) antigen-containing strains of Escherichia coli. Journal of Bacteriology100:730–737.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Berk, S.L., Neumann, P., Chi, D.S. et al. Enhanced virulence effect of K1 polysaccharide in neonatal rats challenged withE. coli . Current Microbiology 8, 297–299 (1983). https://doi.org/10.1007/BF01577731
Issue Date:
DOI: https://doi.org/10.1007/BF01577731